CD9 and carcinoma: Nevertheless, the higher biglycan abundance in the carcinoma EVs was clearly not due to these differences as MTH53A EVs expressed similar CD9 levels as the complex carcinoma cell lines, but biglycan was hardly detectable (Additional file 10).